What you need to know if you have a condition that can affect breathing
Yale School of Medicine experts offer critical COVID-19 guidance for people with chronic pulmonary conditions like asthma, COPD, and cystic fibrosis. (Source: Yale Science and Health News)
Source: Yale Science and Health News - April 7, 2020 Category: Universities & Medical Training Source Type: news
Cystic Fibrosis Diagnosis in Newborns, Children, and Adults Cystic Fibrosis Diagnosis in Newborns, Children, and Adults
Learn more about the available diagnostic modalities for the identification of cystic fibrosis across all age groups.Seminars in Respiratory and Critical Care Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 3, 2020 Category: Consumer Health News Tags: Pulmonary Medicine Journal Article Source Type: news
Drug Trials Snapshots: SYMDEKO
SYMDEKO is a drug for the treatment of cystic fibrosis (CF) in patients 12 years and older, who have specific gene mutations (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 31, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news
5 Live caller 'dancing around days after having coronavirus’
Steve has cystic fibrosis, but says he was up '"dancing around the room" just a few days after having coronavirus. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - March 19, 2020 Category: Consumer Health News Source Type: news
One doctor ’s story: ‘We don’t have the masks, goggles – or the staff’
A senior consultant at a leading hospital for respiratory conditions such as pneumonia and cystic fibrosis talks to the Observer•Coronavirus – latest updates•See all our coronavirus coverageNHS staff are asking the same questions as everyone else about coronavirus. How deadly is it? How do we protect ourselves? Are the government ’s tactics right? And how will the health service cope when – and it is when – it leaves large numbers of people seriously ill, many fighting for their lives? These questions are even more pressing for us because within two weeks we will be part of the frontline against a threat that w...
Source: Guardian Unlimited Science - March 15, 2020 Category: Science Authors: Denis Campbell Tags: Coronavirus outbreak Science Infectious diseases World news UK news Source Type: news
New Financing Could Help BillionToOne Expand Product Offerings
BillionToOne wants to expand its diagnostic offerings and its most recent financing could give it a push in that direction. The Menlo Park, CA-based company has raised $15 million in a follow-on to its series A round.
With this financing, the company BillionToOne has brought in more than $32.5 million. The private company noted previous investors, Hummingbird Ventures and NeoTribe Ventures led the investment round with participation from Y Combinator, Libertus Capital, Pacific 8 Ventures, Civilization Ventures, 500 Startups Istanbul, and HOF Capital.
BillionToOne said it will use the proceeds to support the commercial expa...
Source: MDDI - March 11, 2020 Category: Medical Devices Authors: Omar Ford Tags: IVD Business Source Type: news
FDA grants Breakthrough Therapy Designation for Roche ’s Esbriet (pirfenidone) in unclassifiable interstitial lung disease
Basel, 3 March 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to Esbriet ® (pirfenidone) for adults with unclassifiable interstitial lung disease (uILD). The designation was granted based on data from a Phase II trial, which studied the efficacy and safety of Esbriet in uILD[1]. The study represented the first randomised controlled trial to exclusively enroll patients with progressive fibrosing uILD.“Today’s milestone for Esbriet builds on our continued commitment to improving the standard of care for people ...
Source: Roche Investor Update - March 3, 2020 Category: Pharmaceuticals Source Type: news
Cystic Fibrosis miracle drug battle on as NHS refuse treatment approved 11 years ago
THE DAILY Express today demands a miracle drug for a rare genetic condition finally be made available on the NHS, after an agonising 11-year wait. (Source: Daily Express - Health)
Source: Daily Express - Health - February 29, 2020 Category: Consumer Health News Source Type: news
Ultrasound May ID Children at Risk for Cystic Fibrosis Liver Disease
A heterogeneous liver pattern could indicate a higher risk for advanced cystic fibrosis liver disease (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - February 21, 2020 Category: Respiratory Medicine Tags: Family Medicine, Gastroenterology, Pathology, Pediatrics, Pulmonology, Radiology, Journal, Source Type: news
Ultrasound May ID Children at Risk for Cystic Fibrosis Liver Disease
THURSDAY, Feb. 20, 2020 -- A heterogeneous pattern on ultrasound examination of the liver may help identify children with cystic fibrosis (CF) at increased risk for developing advanced CF liver disease, according to a study published online Feb. 12... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 20, 2020 Category: Pharmaceuticals Source Type: news
Ultrasound identifies kids at risk of CF liver disease
Ultrasound can help clinicians identify children with cystic fibrosis (CF)...Read more on AuntMinnie.comRelated Reading:
Carbon nanotube tomosynthesis may be better for cystic fibrosis
Novel MRI scans could aid in cystic fibrosis
CT can replace x-ray for pediatric cystic fibrosis patients
Growing radiation dose for CF patients highlights risks
MRI still no match for CT in cystic fibrosis (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 18, 2020 Category: Radiology Source Type: news
Researchers find test to ID children at higher risk for cystic fibrosis liver disease
(University of Colorado Anschutz Medical Campus) A major multi-center investigation of children with cystic fibrosis has identified a test that allows earlier identification of those at risk for cystic fibrosis liver disease. The study, which includes 11 clinical sites in North America, was led by Michael Narkewicz, MD, professor of pediatrics from the University of Colorado School of Medicine and Children's Hospital Colorado. The findings of the study are published today ahead of print in The Journal of Pediatrics. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 12, 2020 Category: International Medicine & Public Health Source Type: news
Targeting chronic infections and deadly bacteria
(University of Houston) University of Houston engineering professor Mehmet Orman is examining the life cycle of stubborn, drug-resistant persister cells in recurrent infections to find a way to destroy them. Scientists believe persister cells cause the recurrence of chronic health issues like airway infections in cystic fibrosis patients, urinary tract infections and tuberculosis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 3, 2020 Category: International Medicine & Public Health Source Type: news
Cystic fibrosis drug funding in NZ − have your say
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - January 31, 2020 Category: Drugs & Pharmacology Source Type: news
At last! Cystic Fibrosis crusade poster girl Harriet gets wonder drug
A BEAMING Harriet Corr holds up her first box of life-saving cystic fibrosis pills, after a year of melting hearts in the Daily Express. (Source: Daily Express - Health)
Source: Daily Express - Health - January 24, 2020 Category: Consumer Health News Source Type: news
